The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new generation of oral weight loss medications could transform the fight against obesity and diabetes in low- and ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Results of part 1 of the ESSENCE phase 3 trial, published in The New England Journal of Medicine, demonstrated that a greater proportion ...

The public took major health risks in buying illegally imported anabolic steroids, sedatives, anti-impotence medicines and a ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.